Imara to Present Clinical and Preclinical Data at the American Society of Hematology (ASH) Annual Meeting 2021
04 nov. 2021 09h17 HE
|
Imara, Inc.
Tovinontrine (IMR-687) VOC data in patients with sickle cell disease from ongoing Phase 2a open-label extension study and preclinical models of beta-thalassemia to be presented Oral presentation...
Global Diabetes Diagnostics Market Report 2021: Market to Reach $42.4 Billion by 2026 - U.S. Market is Estimated at $10.8 Billion, While China is Forecast to Reach $5.2 Billion
20 juil. 2021 04h33 HE
|
Research and Markets
Dublin, July 20, 2021 (GLOBE NEWSWIRE) -- The "Diabetes Diagnostics - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global Diabetes...
Imara Announces Recipients of the Second Annual Real Impact Grants Program to Support People Affected by Rare Genetic Blood Disorders
17 juin 2021 07h00 HE
|
Imara, Inc.
BOSTON, June 17, 2021 (GLOBE NEWSWIRE) -- Imara Inc. (Nasdaq: IMRA), a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat patients...
Imara Presents Clinical Data on IMR-687 in Sickle Cell Disease at the European Hematology Association (EHA) Annual Congress
11 juin 2021 03h00 HE
|
Imara, Inc.
Final data from 93-patient Phase 2a clinical trial show lower annualized rate of vaso-occlusive crises (VOCs) and longer time to first VOC on IMR-687 Interim open-label extension clinical trial...
Global Sickle Cell Anemia Market Report 2021-2031: Key Marketed and Pipeline Drugs, Clinical Trials, Recent Events, Regulatory Events, Success Probability, Disease Prevalence, Licensing & Acquisition
09 juin 2021 08h53 HE
|
Research and Markets
Dublin, June 09, 2021 (GLOBE NEWSWIRE) -- The "Market Spotlight: Sickle Cell Anemia" report has been added to ResearchAndMarkets.com's offering. This Market Spotlight report covers the Sickle Cell...
Worldwide Hemoglobin Testing Industry to 2026 - Players Include Abbott, Bio-Rad Laboratories and Danaher Among Others
14 mai 2021 06h53 HE
|
Research and Markets
Dublin, May 14, 2021 (GLOBE NEWSWIRE) -- The "Hemoglobin Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to...
Imara to Webcast Conference Call of First Quarter 2021 Financial Results and Business Highlights
04 mai 2021 07h00 HE
|
Imara, Inc.
BOSTON, May 04, 2021 (GLOBE NEWSWIRE) -- Imara Inc. (Nasdaq: IMRA), a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat patients...
Global Hemoglobin A1C Monitoring Market Report 2021-2027 - U.S. Market is Estimated at $275.9 Million, While China is Forecast to Grow at 11.8% CAGR
23 avr. 2021 05h33 HE
|
Research and Markets
Dublin, April 23, 2021 (GLOBE NEWSWIRE) -- The "Hemoglobin A1C Monitoring - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global Hemoglobin...
Global Blood Therapeutics Announces Participation at Three September Conferences
03 sept. 2015 07h35 HE
|
Global Blood Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Sept. 3, 2015 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ:GBT), a biopharmaceutical company developing novel therapeutics for the treatment of...
Hemoglobin A1c Testing Market to Spike to $1.6 Billion by 2017
27 sept. 2013 07h21 HE
|
Research and Markets
Dublin, Sept. 27, 2013 (GLOBE NEWSWIRE) -- Research and Markets
(http://www.researchandmarkets.com/research/3k6s99/hemoglobin_a1c)
has announced the addition of the "Hemoglobin
A1c...